Background: vitiligo is a common, acquired, discoloration of the skin, characterized by well circumscribed, ivory or chalky white macules and patches. Researchers suggested that vitiligo may arise from autoimmune (AI), genetic, oxidative stress or neural causes. Zinc (Zn) and copper (Cu) are trace elements that are required in minutely small doses. The unique process of keratinization and melanin formation is enzyme-dependent and therefore could be influenced by trace elements deficiencies or excesses as trace elements are involved in enzymatic activities and immunologic reactions. Aim of work: this study aimed to detect the levels and roles of serum Zn and Cu in the pathogenesis of vitiligo. Patients and methods: our study included 50 vitiligo patients and 50 apparently healthy controls. Age of study groups ranged from 15 to 60 years and both sexes. Serum Zn and Cu levels were measured in each study group. Results: serum Zn levels were statistically significant lower in both the studied groups, but in vitiligo group they were much lower than the control group. Serum Cu levels were statistically insignificant higher in vitiligo group than the control group. Conclusion: there is a relationship between vitiligo and serum Zn. Further studies are needed to obtain better knowledge about effect of the trace elements in vitiligo patients.
INTRODUCTION
Vitiligo vulgaris is defined as an idiopathic, acquired type of leukoderma manifested by depigmentation of the epidermis resulting from destruction of melanocytes 
Researchers suggested that vitiligo may arise from autoimmune (AI), genetic, oxidative stress (OS) or neural causes (2) . It is believed that AI etiology is the most plausible factor (3) . The global incidence of vitiligo is less than 1% (4) , with some populations averaging between 2-3% and as high as 16% (5) . Vitiligo is classified into segmental vitiligo (SV) and non-segmental vitiligo (NSV). NSV is the most common type. There is no cure for vitiligo, but several treatment options are available (6) . Conventional treatments for vitiligo included photochemotherapy (psoralen plus ultra-violet A) (PUVA), phototherapy (UVB), vitamin D3 analogues, topical corticosteroids (TCS), topical immunomodulators, excimer laser and surgery. These treatment options have limited success (7) . The best evidence is for applied steroids and the combination of UV light in combination with creams (8) . Zinc (Zn) and copper (Cu) are two of the trace elements that found in small amounts in the body (9) . Zn and Cu are involved in many homeostatic mechanisms of the body, such as specific immunity, inflammation and oxidative stress (OS) (10) . Decreased serum Zn and Cu levels have been reported in vitiligo by some investigators (11) , while others contradicted these findings (11) . Aim of study: this study aimed to detect the possible changes in the metabolism of serum Zn and Cu levels in vitiligo patients and their relation to the etiopathogenesis of vitiligo.
PATIENTS AND METHODS Patients
The present study was conducted on 50 vitiligo patients and on 50 healthy controls. Serum Zn and Cu levels was measured in both groups. 
METHODS
Serum Zn and Cu levels was determined by using Zn and Cu colorimetric method for "in vitro" determination of Zn in serum, plasma or urine and Cu in serum or plasma provided from Quimica Clinica Aplicada S.A, Spain.
Collection and preparation of serum samples
A volume of 3 ml of venous blood was collected from the cases and the control group in special sterile tubes and centrifuged for 10 min at 3000 rpm. The supernatant serum was transferred to a separate sterile tube (Eppendorf tubes) and kept at -20°C in the deep freezer until analysis. Principle of the assay for serum Zn by method of Johnsen and Eliasson (12) and serum Cu by method of Abe et al. (13) Reference 
For quantitative parametric data
Simple one way ANOVA test was used to compare more than two independent groups of the quantitative data. Student t-test was used to compare measures of two independent groups of quantitative data. Pearson correlation coefficients were also processed. The level p≤ 0.05 was considered the cut-off value for significance. The study was approved by the Ethics Board of Ain Shams University.
RESULTS
The present study was conducted on 50 vitiligo patients and on 50 healthy controls. Serum Zn and Cu levels were measured in both groups. Patients were selected from the attendants of outpatient clinic, Department of Dermatology, STDs and Andrology, Faculty of Medicine, Fayoum University and Etsa Govermental Hospital.
Sex distribution of the vitiligo group showed that there were 33 females (66%), 17 males (34%), while in the control healthy group there were 36 females (72%) and 14 males (28%).
The age of both studied groups ranged from 15 to 60 years old, with a mean±SD of 36.74±14 in vitiligo group and with mean±SD of 31.28±9.49 in the control group (Table 1). 23 .02 Serum Cu levels in vitiligo group ranged from 43 to 310 µg/dl with a mean±SD of (141.62±60.56) and in the control group they ranged from 51 to 239 µg/dl with a mean±SD of (128.38±43.03). There was no statistically significant difference with p-value ˃ 0.05 between serum Cu levels and different study group (Table 6 ). Serum Zn levels in vitiligo males patients ranged from 22 to 86 µg/dl with a mean ±SD of (55.12±23.44) and in females ranged from 16 to 71 µg/dl with a mean ±SD of (27.91±13.33) There was a statistically significant difference with p-value > 0.05 between serum Zn levels and sex distribution with higher levels in vitiligo males patients (Table 7) . appeared within last 6 months) in which serum Zn levels ranged from 16 to 86 µg/dl with a mean ±SD of (37.78±21.76) and 9 patients (18%) had stable vitiligo (no new lesions appeared within last 6 months). In which serum Zn levels ranged from 16 to 86 µg/dl with a mean ±SD of (34.33±21.69). There was no statistically significant difference with p-value ˃ 0.05 between serum Zn levels and vitiligo disease activity (Table 11 ). 21 .69 Serum Cu levels in active vitiligo patients ranged from 43 to 310 µg/dl with a mean ±SD of (137.27±55.52) and in stable vitiligo patients ranged from 89 to 310 µg/dl with a mean ±SD of (161.44±80.70). There was no statistically significant difference with p-value ˃ 0.05 between serum Cu levels and vitiligo disease activity (Table 12 ). Among the vitiligo group the vitiligo disease duration was less than 1 year in 6 patients in which serum Zn levels ranged from 18 to 58 µg/dl with mean±SD of (30.67±15.46). The disease duration between 1 to 10 years in 30 patients in which serum Zn levels ranged from 16 to 86 µg/dl with a mean ±SD of (39.83±24.64). The disease duration between 10 to 20 years in 9 patients in which serum Zn levels ranged from 21 to 83 µg/dl with a mean ±SD of (32.56±19.30). The disease duration more than 20 years in 5 patients in which serum Zn levels ranged from 25 to 48 µg/dl with a mean ±SD of (37.20±9.12). There was no statistically significant difference with p-value ˃ 0,05 between serum Zn levels and vitiligo disease duration (Table 13 ). 12 Serum Cu levels in vitiligo patients whom period of disease was less than 1 year ranged from 133 to 310 µg/dl with a mean ±SD of (187.67±69.63). The disease duration between 1 to 10 years serum Cu levels ranged from 55 to 310 µg/dl with a mean ±SD of (143.30±57.82). The disease duration between 10 to 20 years serum Cu levels ranged from 43 to 281 µg/dl with a mean ±SD of (124.56±67.24). The disease duration more than 20 years serum Cu levels ranged from 90 to 131 µg/dl with a mean ±SD of (107±15.19). There was no statistically significant difference with p-value ˃ 0,05 between serum Cu levels and vitiligo disease duration (Table 14) . VASI in vitiligo patients whom duration of disease was less than 1 year ranged from 0.027 to 7.40 with a mean ±SD of (1.57±3.26). The disease duration between 1 to 10 years VASI ranged from 0.0012 to 49.87 with a mean ±SD of (5.11±10.92). The disease duration between 10 to 20 years VASI ranged from 0.0100 to 68.72 with a mean ±SD of (1.83±23.47). The disease duration more than 20 years VASI ranged from 9.300 to 58 with a mean ±SD of (2.24±20.14). There was a statistically significant difference with pvalue ˂ 0.05 between VASI and the vitiligo disease duration with high scale with disease duration between 1 to 10 years (Table 15 ). 14 VASI in vitiligo group ranged between >1 to 25 in 44 patients with serum Zn levels ranged from 16 to 86 µg/dl with a mean± SD of (35.48±20.22) . VASI in vitiligo group ranged between < 25 to< 60 in 6 patients with serum Zn levels ranged from22 to 81 µg/dl with a mean± SD of (49.50±28.82). There was no statistically significant difference with p-value ˃ 0,05 between VASI and serum Zn levels in vitiligo group (Table 16 ). VASI in vitiligo group ranged between >1 to 25 with serum Cu levels ranged from 55 to 310 µg/dl with a mean± SD of (144.23±61.84). VASI in vitiligo group ranged between < 25 to< 60 with serum Cu levels ranged from 43 to 190 µg/dl with a mean± SD of (122.50±50.50). There was no statistically significant difference with p-value ˃ 0.05 between VASI and serum Cu levels in vitiligo group (Table 17) . 
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DISCUSSION
Vitiligo is an acquired skin disease characterized by white areas of the skin. The disease may affect individuals of both sexes and is mostly characterized by loss of melanocytes (14) . The etiology of vitiligo and the causes of melanocyte death are not clear. At least three pathogenic mechanisms immunological, neural and biochemical (15) have been suggested, but none can completely explain the disease. Some findings showed that OS may be an important phenomenon in the pathophysiology of vitiligo (16) . Zn is one of the important trace elements related to health and disease (17) . Zn in combination with other micronutrients such as Cu, cobalt, nickel, iron, manganese and Ca ++ (18) plays an important role in the process of melanogenesis (19) . The present study was designed to assess serum Zn and Cu levels in vitiligo patients and correlate it with age, sex, disease duration, activity, disease severity expressed clinically via VASI and compare it with their levels in healthy control individuals to understand their roles in pathogenesis of vitiligo.
Our study included 50 patients with vitiligo of both sexes: 33 females (60%) and 17 males (34%). Fifty volunteers were included as a control group. Age in vitiligo group ranged between 15 to 60 years with a mean ± SD of (36.74±14) years and in control group ranged from 15 to 60 years with a mean ± SD of (31.28±9.49) years.
Our data revealed that serum Zn levels was significantly low in vitiligo patients ranged from 16 to 86 µg/dl with a mean ± SD of (37.16±21.56) compared to the controls, ranged from 17 to 127 µg/dl with a mean ± SD (50.49±23.02), these results are consistent with results of Wang et al. (20) , Yao (21) , Wang (22) , Wu et al. (23) , Wang et al. (24) , Kang et al. (25) , Zhou et al. (26) , Wang and Chen (27) , Wang and Xu (28) , Shi et al. (29) , Tu et al. (30) and Li et al. (31) whose researches on chinese vitilgo patients showed that serum Zn levels were also significantly lower in vitiligo patients than in healthy controls (32) . Also, Shameer et al. (19) , Haider (11) , Bruske and Salfeld (33) indicated that serum Zn decreased in vitiligo patients. This is also in agreement with results of Medhavi et al. (34) , Wasan and Al-Rubayee (35) , Molokhia and Portnoy (36) who observed a significant decrease in serum Zn level in vitiligo patients compared to the control group.
Arora et al. (17) showed that serum Zn was lower in vitiligo patients than the control group, but this difference was not statistically important. Interestingly, Inamadar and Palit (18) reported appearance of vitiligo-like depigmented cutaneous lesions in two siblings with acrodermatitis enteropathica who developed decreased serum Zn level due to discontinuation of Zn supplements.
On the contrary, Haider et al. (11) obseved that serum Zn level was found to be increased in the patients than the controls but it was not statistically significant.
Basha et al. (37) showed that the mean Zn level in both groups was found to be within the normal reference range, but in vitiligo patients the mean Zn levels was observed to be statistically significantly higher than that of controls.
Also, Helmy et al. (38) showed that serum Zn levels were significantly higher in the active vitiligo patients compared to the controls.
The present study also measured serum Cu and found insignificantly higher levels in vitilgo 279 group and they ranged from 43 to 310 µg/dl with mean ± SD of (141.62±60.56) than the controls, (ranged from 51 to 239 µg/dl) with a mean ± SD of (128.38±43.03). In the presence of Zn deficiency, absorption of Cu is enhanced (39) . As a result, reduced serum Zn levels was accompanied by elevated serum Cu levels (40) . Also, Helmy et al. (38) showed that Cu levels were significantly higher in active vitiligo patients compared to the controls.
Melanins are colloidal pigments and have a high affinity for metal ions; therefore, Cu and Zn are found in high levels in pigmented tissues involved in melanin synthesis. As melanocytes degenerate in vitiligo patients, less Cu and Zn are utilized for the melanin synthesis, which consequently raise levels of Cu and Zn in serum in vitiligo patients (41) . On the contrary, Wang (22) , Wasan and Al-Rubayee (35) , Wu et al. (23) , Kang et al. (25) , Wang et al. (27) , Shi et al. (29) and Li et al. 
, Yao
, Wang et al. (24) , Gu et al. (42) , Haider (11) , Shameer et al. (19) , Li and Zhu (43) , Zhou et al. (26) , Wang and Xu (28) , Tu et al. (30) and Bruske and Salfeld (33) presented significant decrease of Cu level in vitiligo patients. Cu and Zn are antioxidants involved in destruction of free radicals and potential antiapoptotic factors for protecting cell proteins from oxidation. Furthermore, Cu and Zn may play roles in stimulating cell-mediated immunity responses, synthesizing and releasing of melanocyte stimulating hormone, which are also important in melanogenesis (18) . So, decreased serum Zn and Cu levels can cause vitiligo.
Our study showed more vitiligo females patients, which is similar to other studies such as Akay et al. (44) , Karelson et al. (45) and Akrem et al. (46) which explained by more awareness of the women to cosmetic disfigurement and therefore more likely to seek treatment. However, Liu (47) , Majumder (48) and Mosher et al. (49) showed both sexes were equally affected.
Basha et al. (37) and Arora et al. (17) reported that there was no statistically significant difference of the serum Zn level and sex distribution. Conversely, our study showed that serum Zn levels was significantly higher in vitiligo males patients than vitiligo females. Also, there was a tendency to be a statistically significant higher in male control group than female control group. Our study showed that there was a statistically significant difference between VASI and age of vitiligo group and between VASI and disease duration. Also, statistically significant was a positive correlation between VASI and age. Also, this study found a tendency to be statistically significant negative correlation between serum Cu levels and vitiligo disease duration. Our study found that serum Cu was insignificantly higher in vitilgo group compared to the control group. There was no statistically significant difference between serum Zn and Cu levels and age of vitiligo group. There was no statistically significant difference between serum Zn and Cu levels and vitiligo disease activity. There was no statistically significant difference between serum Cu levels and sex distribution in the vitiligo group and in the control group. There was no statistically significant difference between serum Zn and Cu levels and the vitiligo disease duration. There was no statistically significant difference between VASI and serum Zn and Cu levels in vitiligo group.
CONCLUSION
In our study serum Zn levels were lower in the different studied groups, but in the vitiligo group it was much lower and insignificantly higher serum Cu levels in the vitilgo group compared to the control group. So serum Zn and Cu may have an effect on the vitiligo disease as Zn in combination with other micronutrients such as Cu, cobalt, nickel, iron, manganese and Ca ++ plays an important role in the process of melanogensis. 
